TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
DSGN

Design Therapeutics Inc

Healthcare · Biotechnology · —

12.30$ -0.9% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Design Therapeutics Inc (DSGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 215 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet DSGN
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
300 290 279 270 262 252 237 223 212 226 230 215
295 285 274 265 257 248 234 220 209 224 227 212
28 21 29 46 30 23 14 20 15 17 13 13
291 282 271 261 254 245 230 216 206 220 223 207
1.2 1.4 1.7 1.4 1.2 1.3 1.4 1.3 1.4 1.7 1.8 1.8
-1.2 – – – – – – – – – – –
15 12 9.2 8.3 9.2 10.0 9.6 9.8 12 14 12 13
12 9.6 7.1 6.4 7.4 8.5 8.2 8.7 11 13 10 11
0.7 0.7 0.7 0.8 0.8 0.8 0.8 0.8 0.9 0.9 0.5 –
2.2 1.9 1.4 1.3 1.5 2.2 3.2 1.0 1.9 2.3 2.3 3.1
285 278 270 261 252 242 228 213 200 213 218 202
-166 -178 -189 -201 -214 -227 -245 -264 -281 -297 -315 -335
56 56 56 57 57 57 57 57 57 57 61 63

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?